{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"d665c048bc7348743c35513f8a761032794acd46e09848c273fcd1a6aae5b7aa","attributes":{"feedName":"fda","feedSource":"fda","title":"Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab","description":"AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are within expiry to the healthcare provider level. These lots are being recalled out of an abundance of caution following an F","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pacifico-national-inc-dba-amex-pharmacy-issues-voluntary-nationwide-recall-all-lots-bevacizumab","publicationDate":"2019-08-30T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals","consumers"],"categories":["drugs"],"contaminants":["other"],"distribution":["AR","AZ","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","MI","MN","MO","MS","NC","ND","NE","NH","NJ","NV","NY","OH","OK","OR","PA","RI","SD","TN","TX","UT","WA","WI","WV","TT"],"risk":"possible","token":"5d9e68f98b079e002a252355"}}}